Ramipril

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on May 30, 2019.

Return to the list of Patented Medicine Litigation page.





Ramipril

ALTACE, ALTACE HCT, RAMACE – Sanofi-aventis Canada Inc. (NOC Search)

Patents:

  • 1187087: GENPHARM, TEVA, NOVOPHARM, APOTEX, RIVA
  • 1246457: GENPHARM, PHARMASCIENCE, RIVA, NOVOPHARM, APOTEX
  • 1338344: APOTEX, PHARMASCIENCE
  • 1341196: APOTEX, NOVOPHARM, RATIOPHARM, APOTEX, TEVA
  • 1341206: RATIOPHARM, APOTEX, GENPHARM, PRO DOC, NOVOPHARM, RANBAXY, RIVA, PHARMASCIENCE, SANDOZ, MYLAN, TEVA, APOTEX, RATIOPHARM, APOTEX, COBALT
  • 1341296: TEVA, NOVOPHARM
  • 1341330: NOVOPHARM, APOTEX
  • 2023089: GENPHARM, PHARMASCIENCE, MYLAN, RIVA, COBALT, NOVOPHARM, APOTEX
  • 2055948: PHARMASCIENCE, SANDOZ, MYLAN, APOTEX, COBALT, GENPHARM, NOVOPHARM, RIVA
  • 2382387: COBALT, APOTEX, MYLAN, PHARMASCIENCE, SANDOZ, RIVA, NOVOPHARM, GENPHARM
  • 2382549: RIVA, NOVOPHARM, SANDOZ, PHARMASCIENCE, MYLAN, COBALT, APOTEX

APOTEX

APOTEX, RATIOPHARM

COBALT

GENPHARM

MYLAN

NOVOPHARM

PHARMASCIENCE

PRO DOC

RANBAXY

RATIOPHARM, APOTEX

RIVA

SANDOZ

TEVA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property